Literature DB >> 22720197

Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow-up.

Gianluca Rigatelli, Fabio Dell'avvocata, Paolo Cardaioli, Massimo Giordan, Gabriele Braggion, Silvio Aggio, Roberto L'erario, Mauro Chinaglia.   

Abstract

OBJECTIVE: We sought to assess the long-term faith of migraine in patients with high risk anatomic and functional characteristics predisposing to paradoxical embolism submitted to patent foramen ovale (PFO) transcatheter closure.
METHODS: In a prospective single-center non randomized registry from January 2004 to January 2010 we enrolled 80 patients (58 female, mean age 42±2.7 years, 63 patients with aura) submitted to transcatheter PFO closure in our center. All patients fulfilled the following criteria: basal shunt and shower/curtain shunt pattern on transcranial Doppler and echocardiography, presence of interatrial septal aneurysm (ISA) and Eustachian valve, 3-4 class MIDAS score, coagulation abnormalities, medication-refractory migraine with or without aura. Migraine Disability Assessment Score (MIDAS) was used to assess the incidence and severity of migraine before and after mechanical closure. High risk features for paradoxical embolism included all of the following.
RESULTS: Percutaneous closure was successful in all cases (occlusion rate 91.2%), using a specifically anatomically-driven tailored strategy, with no peri-procedural or in-hospital complications; 70/80 of patients (87.5%) reported improved migraine symptomatology (mean MIDAS score decreased 33.4±6.7 to 10.6±9.8, p<0.03) whereas 12.5% reported no amelioration: none of the patients reported worsening of the previous migraine symptoms. Auras were definitively cured in 61/63 patients with migraine with aura (96.8%).
CONCLUSIONS: Transcatheter PFO closure in a selected population of patients with severe migraine at high risk of paradoxical embolism resulted in a significant reduction in migraine over a long-term follow-up.

Entities:  

Keywords:  Migraine; patent foramen ovale; stroke; transcatheter closure

Year:  2012        PMID: 22720197      PMCID: PMC3371619     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  24 in total

1.  Inherited thrombophilic conditions, patent foramen ovale and juvenile ischaemic Stroke.

Authors:  P Cerrato; D Imperiale; M Bazzan; L Lopiano; C Baima; M Grasso; M Morello; B Bergamasco
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

3.  An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.

Authors:  W F Stewart; R B Lipton; J Whyte; A Dowson; K Kolodner; J N Liberman; J Sawyer
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

4.  Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients.

Authors:  Yuji Ueno; Yoshiaki Shimada; Ryota Tanaka; Nobukazu Miyamoto; Yasutaka Tanaka; Nobutaka Hattori; Takao Urabe
Journal:  Cerebrovasc Dis       Date:  2010-04-27       Impact factor: 2.762

5.  Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study.

Authors:  G P Anzola; M Magoni; M Guindani; L Rozzini; G Dalla Volta
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

6.  May migraine post-patent foramen ovale closure sustain the microembolic genesis of cortical spread depression?

Authors:  Gianluca Rigatelli; Paolo Cardaioli; Fabio Dell'Avvocata; Massimo Giordan; Aravinda Nanjundappa; Sangeeta Mandapaka; Mauro Chinaglia
Journal:  Cardiovasc Revasc Med       Date:  2010-12-30

7.  Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device.

Authors:  C Boutin; N N Musewe; J F Smallhorn; J D Dyck; T Kobayashi; L N Benson
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

8.  Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  M A Sloan; A V Alexandrov; C H Tegeler; M P Spencer; L R Caplan; E Feldmann; L R Wechsler; D W Newell; C R Gomez; V L Babikian; D Lefkowitz; R S Goldman; C Armon; C Y Hsu; D S Goodin
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

9.  The association of different right atrium anatomical-functional characteristics correlates with the risk of paradoxical stroke: an intracardiac echocardiographic study.

Authors:  Gianluca Rigatelli; Paolo Cardaioli; Fabio Dell'Avvocata; Massimo Giordan; Gabriele Braggion; Silvio Aggio; Mauro Chinaglia; Loris Roncon
Journal:  J Interv Cardiol       Date:  2008-08       Impact factor: 2.279

10.  Transcatheter interatrial shunt closure as a cure for migraine: can it be justified by paradoxical embolism-risk-driven criteria?

Authors:  Gianluca Rigatelli; Paolo Cardaioli; Massimo Giordan; Fabio Dell'Avvocata; Gabriele Braggion; Mauro Chianaglia; Loris Roncon
Journal:  Am J Med Sci       Date:  2009-03       Impact factor: 2.378

View more
  7 in total

Review 1.  Migraine and patent foramen ovale.

Authors:  Jessica Ailani
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

2.  Coincidental Impact of Transcatheter Patent Foramen Ovale Closure on Migraine with and without Aura - A Comprehensive Meta-Analysis.

Authors:  Siddak M Kanwar; Amit Noheria; Christopher V DeSimone; Alejandro A Rabinstein; Samuel J Asirvatham
Journal:  Clin Trials Regul Sci Cardiol       Date:  2016-03-01

Review 3.  Surgical and catheter procedures in adult congenital heart disease: simple national statistics of the UK tell us something.

Authors:  Hideki Uemura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-06-05

4.  Transcatheter Closure of Patent Foramen Ovale: A Single Center Experience.

Authors:  Ivan Milev; Planinka Zafirovska; Zan Zimbakov; Shpend Idrizi; Vilma Ampova-Sokolov; Emilija Gorgieva; Liljana Ilievska; Goce Tosheski; Nikola Hristov; Ljubica Georgievska-Ismail; Tanja Anguseva; Zan Mitrev
Journal:  Open Access Maced J Med Sci       Date:  2016-10-05

Review 5.  Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.

Authors:  Yu-Jie Shi; Jun Lv; Xing-Ting Han; Guo-Gang Luo
Journal:  BMC Cardiovasc Disord       Date:  2017-07-26       Impact factor: 2.298

6.  Patent Foramen Ovale Closure for Treating Migraine: A Meta-Analysis.

Authors:  Yu Zhang; Haijiao Wang; Ling Liu
Journal:  J Interv Cardiol       Date:  2022-02-02       Impact factor: 2.279

7.  A Nomogram for the Prediction of Cessation of Migraine Among Patients With Patent Foramen Ovale After Percutaneous Closure.

Authors:  Enfa Zhao; Hang Xie; Yushun Zhang
Journal:  Front Neurol       Date:  2020-10-23       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.